Evaluating ChatGPT's efficacy in assessing the safety of non-prescription medications and supplements in patients with kidney disease
Background This study investigated the efficacy of ChatGPT-3.5 and ChatGPT-4 in assessing drug safety for patients with kidney diseases, comparing their performance to Micromedex, a well-established drug information source. Despite the perception of non-prescription medications and supplements as sa...
Main Authors: | Mohammad S. Sheikh, Erin F. Barreto, Jing Miao, Charat Thongprayoon, James R Gregoire, Benjamin Dreesman, Stephen B. Erickson, Iasmina M. Craici, Wisit Cheungpasitporn |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Digital Health |
Online Access: | https://doi.org/10.1177/20552076241248082 |
Similar Items
-
Personalized Medicine Transformed: ChatGPT’s Contribution to Continuous Renal Replacement Therapy Alarm Management in Intensive Care Units
by: Mohammad S. Sheikh, et al.
Published: (2024-02-01) -
Empowering inclusivity: improving readability of living kidney donation information with ChatGPT
by: Oscar A. Garcia Valencia, et al.
Published: (2024-04-01) -
Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT
by: Jing Miao, et al.
Published: (2023-12-01) -
Navigating the Landscape of Personalized Medicine: The Relevance of ChatGPT, BingChat, and Bard AI in Nephrology Literature Searches
by: Noppawit Aiumtrakul, et al.
Published: (2023-09-01) -
Examining the Validity of ChatGPT in Identifying Relevant Nephrology Literature: Findings and Implications
by: Supawadee Suppadungsuk, et al.
Published: (2023-08-01)